GCM
ABBV icon

Gibraltar Capital Management’s AbbVie ABBV Stock Holding History

Gibraltar Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-4,111
Closed -$630K – 75
2022
Q2 		$630K Sell
4,111
-27
-0.7% -$4.13K 0.31% 35
2022
Q1 		$671K Sell
4,138
-2,408
-37% -$350K 0.28% 36
2021
Q4 		$886K Sell
6,546
-2,059
-24% -$243K 0.4% 35
2021
Q3 		$928K Sell
8,605
-364
-4% -$41.6K 0.47% 35
2021
Q2 		$1.04M Sell
8,969
-42,267
-82% -$4.76M 0.52% 34
2021
Q1 		$5.56M Buy
51,236
+7,956
+18% +$851K 2.86% 17
2020
Q4 		$4.64M Buy
43,280
+1,714
+4% +$165K 2.76% 17
2020
Q3 		$3.64M Buy
41,566
+526
+1% +$49.5K 2.54% 20
2020
Q2 		$4.03M Buy
41,040
+1,381
+3% +$122K 2.96% 15
2020
Q1 		$3.02M Buy
39,659
+1,348
+4% +$115K 2.15% 21
2019
Q4 		$3.39M Buy
38,311
+1,378
+4% +$114K 2.04% 22
2019
Q3 		$2.8M Buy
36,933
+4,521
+14% +$310K 2.11% 24
2019
Q2 		$2.36M Buy
32,412
+19
+0.1% +$1.49K 2.43% 20
2019
Q1 		$2.61M Buy
+32,393
New +$2.65M 2.62% 21

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Gibraltar Capital Management's ABBV Position: Q3 2022 in Review

Gibraltar Capital Management sold out of AbbVie (ABBV) in Q3 2022, closing a stake of 4,111 shares — an estimated $630K sold.

Gibraltar Capital Management first reported a position in ABBV in Q1 2019 and held it in 14 quarters. The position peaked at $5.56M in Q1 2021. 2,968 funds tracked by Wall St. Rank hold ABBV as of Q3 2022.

  • Gibraltar Capital Management reported no remaining AbbVie position as of Q3 2022 after selling out during the quarter.
  • Gibraltar Capital Management sold 4,111 AbbVie shares in Q3 2022, an estimated $630K.
  • Gibraltar Capital Management first reported a position in AbbVie in Q1 2019 and held it in 14 quarters.
  • Gibraltar Capital Management's AbbVie position peaked at $5.56M in Q1 2021.
  • 2,968 funds tracked by Wall St. Rank held AbbVie as of Q3 2022.

Based on Gibraltar Capital Management's 13F filing for Q3 2022, filed 27 Oct 2022.